Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Nvidia, Microsoft, Kimberly-Clark: 'Mad Money' Lightning Round
By Scott Rutt
Jan 22, 2019 8:40 PM EST
PRESS RELEASES
Ligand Announces Clinical And Regulatory Progress By Multiple Partners With OmniAb® Antibodies
By Business Wire
Nov 23, 2020 8:30 AM EST
PRESS RELEASES
Ligand's Captisol Technology Plays Key Role In The Manufacture Of Gilead's Veklury, The First FDA-Approved COVID-19 Treatment
By Business Wire
Oct 23, 2020 8:30 AM EDT
PRESS RELEASES
Ligand Provides Highlights From Today's Investor Day Event
By Business Wire
Oct 20, 2020 2:05 PM EDT
PRESS RELEASES
Ligand To Divest Vernalis Research Operations
By Business Wire
Oct 12, 2020 9:00 AM EDT
PRESS RELEASES
Ligand To Host Virtual Investor Day On October 20th
By Business Wire
Oct 2, 2020 8:00 AM EDT
PRESS RELEASES
Ligand Announces Expiration Of Tender Offer For Shares Of Pfenex Inc.
By Business Wire
Sep 30, 2020 8:00 AM EDT
PRESS RELEASES
Ligand Expands OmniAb® Antibody Discovery Platform Through The Acquisitions Of XCella Biosciences And Taurus Biosciences
By Business Wire
Sep 10, 2020 8:00 AM EDT
PRESS RELEASES
Ligand Pharmaceuticals Management To Present At The H.C. Wainwright 22nd Annual Global Investment Virtual Conference
By Business Wire
Sep 1, 2020 4:02 PM EDT
PRESS RELEASES
Ligand Commences Previously Announced Cash Tender Offer To Acquire Pfenex Inc.
By Business Wire
Aug 31, 2020 9:00 AM EDT
PRESS RELEASES
Ligand OmniAb® Partner Immunovant Announced Positive Topline Results From Multicenter, Placebo-Controlled Phase 2a Trial Of IMVT-1401 In Myasthenia Gravis
By Business Wire
Aug 25, 2020 4:15 PM EDT
PRESS RELEASES
Ligand Announces Amgen's KYPROLIS® Approved By FDA As Combination Regimen With DARZALEX® And Dexamethasone In Once- And Twice-Weekly Dosing Regimens For Patients With Relapsed/Refractory Multiple Myeloma
By Business Wire
Aug 24, 2020 8:30 AM EDT
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Pfenex, Inc.
By PR Newswire
Aug 11, 2020 9:05 PM EDT
PRESS RELEASES
PFENEX ALERT: Bragar Eagel & Squire, P.C. Investigates Sale Of PFNX And Encourages Investors To Contact The Firm
By Business Wire
Aug 10, 2020 8:40 PM EDT
PRESS RELEASES
Ligand To Acquire Pfenex Inc.
By Business Wire
Aug 10, 2020 5:36 PM EDT
PRESS RELEASES
Functional, Human Antibodies Targeting SARS-CoV-2 Discovered Using IPA's Proprietary B Cell Select™ And Single Step Cloning Hybridoma Technologies
By PR Newswire
Jul 13, 2020 7:51 AM EDT
PRESS RELEASES
IPA Confirms Discovery Of Fully Human, Potent, Neutralizing Antibodies Targeting SARS-CoV-2
By PR Newswire
Jun 29, 2020 12:48 PM EDT
PRESS RELEASES
Ligand Announces An Expansion Of Vernalis Collaboration With Servier For Research On Novel Oncology Targets
By Business Wire
Jun 15, 2020 8:30 AM EDT
PRESS RELEASES
Ligand CEO Issues Letter To Captisol Customers
By Business Wire
Jun 1, 2020 4:53 PM EDT
PRESS RELEASES
Ligand Announces Icagen's Expansion Of Collaboration With Roche To Develop And Commercialize Therapies For Neurological Diseases
By Business Wire
May 29, 2020 8:00 AM EDT
PRESS RELEASES
Ligand Earns $3 Million Milestone Payment From Palvella Therapeutics
By Business Wire
May 28, 2020 4:22 PM EDT
PRESS RELEASES
ImmunoPrecise Provides Updates On B Cell Select™ And Deep Display™ Programs For SARS-CoV-2 Antibody Discovery
By PR Newswire
Apr 17, 2020 8:00 AM EDT
PRESS RELEASES
Ligand Provides A Corporate Update And Announces May 6th As The Date For First Quarter Earnings Call
By Business Wire
Apr 6, 2020 7:00 AM EDT
PRESS RELEASES
Ligand Completes Acquisition Of Icagen Core Assets, Partnered Programs And Ion Channel Technologies
By Business Wire
Apr 2, 2020 4:02 PM EDT
PRESS RELEASES
Ligand's Presentation At The Barclays Global Healthcare Conference Now A Webcast Only, New Slides Available On Ligand.com
By Business Wire
Mar 10, 2020 8:00 AM EDT